Human Fas/TNFRSF6/CD95 Quantikine ELISA Kit
| Name | Human Fas/TNFRSF6/CD95 Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DFS00 |
| Category | ELISA Kit |
| Prices | $509.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (100 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL), Citrate Plasma (10 uL) |
| Sensitivity | 20 pg/mL |
| Range | 31.2 - 2,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human sFas Immunoassay is a 4.5 hour solid phase ELISA designed to measure human sFas in cell culture supernates, serum, and plasma |
| Gene | FAS |
| Supplier Page | Shop |
Product images
Product References
FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell - FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell
Sehgal L, Mathur R, Braun FK, Wise JF, Berkova Z, Neelapu S, Kwak LW, Samaniego F. Leukemia. 2014 Dec;28(12):2376-87.
High admission glucose levels increase Fas apoptosis and mortality in patients - High admission glucose levels increase Fas apoptosis and mortality in patients
Chang J, Zhang G, Zhang L, Hou YP, Liu XL, Zhang L. Cardiovasc Diabetol. 2013 Nov 15;12:171.
Effect of quinapril on in-stent restenosis and relation to plasma apoptosis - Effect of quinapril on in-stent restenosis and relation to plasma apoptosis
Deftereos S, Giannopoulos G, Kossyvakis C, Kaoukis A, Raisakis K, Driva M, Panagopoulou V, Lappos S, Rentoukas I, Pyrgakis V, Alpert MA. Am J Cardiol. 2010 Jan 1;105(1):54-8.
A 60-s postconditioning protocol by percutaneous coronary intervention inhibits - A 60-s postconditioning protocol by percutaneous coronary intervention inhibits
Zhao WS, Xu L, Wang LF, Zhang L, Zhang ZY, Liu Y, Liu XL, Yang XC, Cui L, Zhang L. Apoptosis. 2009 Oct;14(10):1204-11.
Fas expression in conjunctival epithelial cells of patients with cystic fibrosis. - Fas expression in conjunctival epithelial cells of patients with cystic fibrosis.
Mrugacz M. J Interferon Cytokine Res. 2009 Nov;29(11):735-40.
Soluble and membrane levels of molecules involved in the interaction between - Soluble and membrane levels of molecules involved in the interaction between
Perez-Andres M, Almeida J, Martin-Ayuso M, De Las Heras N, Moro MJ, Martin-Nunez G, Galende J, Cuello R, Abuin I, Moreno I, Dominguez M, Hernandez J, Mateo G, San Miguel JF, Orfao A. Int J Cancer. 2009 Jan 15;124(2):367-75.
Prognostic value of apoptosis markers in advanced heart failure patients. - Prognostic value of apoptosis markers in advanced heart failure patients.
Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, Richter B, Hulsmann M, Berger R, Mortl D, Huber K, Wojta J, Pacher R. Eur Heart J. 2009 Apr;30(7):789-96.
Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, - Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines,
Kourea K, Parissis JT, Farmakis D, Panou F, Paraskevaidis I, Venetsanou K, Filippatos G, Kremastinos DT. Atherosclerosis. 2008 Jul;199(1):215-21. Epub 2007 Nov 7.
Soluble Fas--a promising novel urinary marker for the detection of recurrent - Soluble Fas--a promising novel urinary marker for the detection of recurrent
Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF. Cancer. 2006 Apr 15;106(8):1701-7.
High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in - High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in
Zhang L, Zhang L, Li YH, Zhang HY, Chen ML, Gao MM, Hu AH, Yang HS, Yang HS. Eur J Clin Invest. 2005 Mar;35(3):164-70.